Charles E. Schwartz

Summary

Greenwood Genetic Center, Former Director of Research; Adjunct Professor of Biology, University of South Carolina; Director, American Board of Medical Genetics, 2006-2011 and President 2009; Robert Guthrie Award for Advances in Biochemical and Molecular Genetics, 2003.

Genetics Medical Genetics Molecular Biology

Editorial Board Member

Work details

None

Retired

None

PeerJ Contributions

Edited 3

Academic Editor on

November 15, 2019

Differences in the importance of microcephaly, dysmorphism, and epilepsy in the detection of pathogenic CNVs in ID and ASD patients

Zuzana Capkova, Pavlina Capkova, Josef Srovnal, Katerina Staffova, Vera Becvarova, Marie Trkova, Katerina Adamova, Alena Santava, Vaclava Curtisova, Marian Hajduch, Martin Prochazka

https://doi.org/10.7717/peerj.7979 PubMed 31741789

January 9, 2019

MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism

Pavlina Capkova, Josef Srovnal, Zuzana Capkova, Katerina Staffova, Vera Becvarova, Marie Trkova, Katerina Adamova, Alena Santava, Vaclava Curtisova, Marian Hajduch, Martin Prochazka

https://doi.org/10.7717/peerj.6183 PubMed 30647996

April 22, 2014

A new direction for prenatal chromosome microarray testing: software-targeting for detection of clinically significant chromosome imbalance without equivocal findings

Joo Wook Ahn, Susan Bint, Melita D. Irving, Phillipa M. Kyle, Ranjit Akolekar, Shehla N. Mohammed, Caroline Mackie Ogilvie

https://doi.org/10.7717/peerj.354 PubMed 24795849